Biodexa Pharmaceuticals Plc
BDRX
←Back to Recent Filings
| Filing |
DATE |
FP |
FY |
End Date |
URL |
VIEW |
|
| 6-K |
9/12/2025 |
Q2 |
2025 |
6/30/2025 |
SEC |
view |
|
| 20-F |
4/12/2025 |
Q4 |
2024 |
12/31/2024 |
SEC |
view |
|
| 6-K |
9/26/2024 |
Q2 |
2024 |
6/30/2024 |
SEC |
view |
|
| 20-F |
4/19/2024 |
Q4 |
2023 |
12/31/2023 |
SEC |
view |
|
| WIREPR |
1/22/2024 |
Q4 |
2023 |
12/31/2023 |
WIRE |
view |
data |
| 6-K |
9/29/2023 |
Q2 |
2023 |
6/30/2023 |
SEC |
view |
|
| 20-F/A |
5/5/2023 |
Q4 |
2022 |
12/31/2022 |
SEC |
view |
|
| 20-F |
4/28/2023 |
Q4 |
2022 |
12/31/2022 |
SEC |
view |
|
| 20-F |
4/28/2023 |
Q4 |
2022 |
12/31/2022 |
SEC |
view |
|
| 6-K/A |
10/4/2022 |
Q2 |
2022 |
6/30/2022 |
SEC |
view |
|
| 20-F |
4/26/2022 |
Q4 |
2021 |
12/31/2021 |
SEC |
view |
|
| 20-F |
4/30/2021 |
Q4 |
2020 |
12/31/2020 |
SEC |
view |
|
| 20-F |
6/15/2020 |
Q4 |
2019 |
12/31/2019 |
SEC |
view |
|
| 20-F |
4/30/2019 |
Q4 |
2018 |
12/31/2018 |
SEC |
view |
|
| 20-F |
4/24/2018 |
Q4 |
2017 |
12/31/2017 |
SEC |
view |
|